STOCK TITAN

PhenixFIN Corp - PFX STOCK NEWS

Welcome to our dedicated news page for PhenixFIN (Ticker: PFX), a resource for investors and traders seeking the latest updates and insights on PhenixFIN.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PhenixFIN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PhenixFIN's position in the market.

Rhea-AI Summary
PhenixFIN Corporation (PFX) reported a 23% growth in net asset value (NAV) per share in the first quarter of 2024, reaching $73.14 per share as of December 31, 2023. The company achieved a total investment income of $5.7 million, with a weighted average yield of 13.0% on debt and other income producing investments. However, the company had 4 portfolio company investments on non-accrual status with a fair market value of $8.9 million, indicating potential risks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
-
Rhea-AI Summary
PhenixFIN Corporation (NASDAQ: PFX, PFXNZ) reported a 23% growth in NAV per share and more than doubled NII per share for the fiscal year ended 2023. The company achieved a total investment income of $5.7 million, with a net investment income of $1.9 million. The total net asset value (NAV) reached $146.7 million, or $70.75 per share as of September 30, 2023, compared to $57.49 per share in the previous year. The weighted average yield was 13.3% on debt and other income producing investments as of the fiscal year end. The company also repurchased 28,416 shares in Fiscal Year 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
PhenixFIN Corporation announces financial results for Q3 2023 with total investment income of $14.5 million and net investment income of $4.6 million. NAV is $140.0 million or $67.01 per share. Expanded repurchase program to $35 million. CEO cites strong performance and increased investment activity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.65%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.2%
Tags
PhenixFIN Corp

Nasdaq:PFX

PFX Rankings

PFX Stock Data

91.18M
1.54M
19.64%
32.41%
0.13%
Securities and Commodity Exchanges
Finance and Insurance
Link
US
New York

About PFX

medley capital corp (mcc) is a financial services company located in 375 park ave, new york, new york, united states.